Teprenone capsules and rabeprazole are not generally used alone to treat H. pylori, and anti-H. pylori is routinely recommended for quadruple therapy.
Teprenone capsule belongs to the gastric mucosal protection agent, mainly used in acute gastritis, gastric ulcer on the gastric mucosal erosion, bleeding improvement. Rabeprazole is a proton pump inhibitor, which can inhibit gastric acid secretion.
The treatment of Helicobacter pylori in the clinic usually uses a quadruple treatment program, choosing two antimicrobial drugs (e.g., amoxicillin, clarithromycin, metronidazole, etc.), a proton pump inhibitor (e.g., rabeprazole, omeprazole, etc.), and a bismuth agent (e.g., bismuth potassium citrate, colloidal bismuth in pectin, etc.).
Treatment of H. pylori should choose a high eradication rate of the treatment program to strive for a successful eradication, during the standardized combination of drugs, need to be reviewed on time.